Ubiquitin-protein ligase E3a (UBE3A) as a new biomarker of cardiac hypertrophy in cell models

Cardiac hypertrophy is widely diagnosed in clinical cardiac disorders. The pathophysiology of hypertrophy is complex and multifactorial, a series of molecular and cellular changes are participated, such as activation of different signaling pathways, a switch of fetal gene program in the myocardium,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Kai-Chun, Li, Yingxiao, Chang, Wei-Ting, Chen, Zhih-Cherng, Cheng, Juei-Tang, Tsai, Cheng-Chia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Food and Drug Administration 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298619/
https://www.ncbi.nlm.nih.gov/pubmed/30648591
http://dx.doi.org/10.1016/j.jfda.2018.08.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298619/
https://www.ncbi.nlm.nih.gov/pubmed/30648591
http://dx.doi.org/10.1016/j.jfda.2018.08.002

Ejemplares similares